AU2002360819A1 - Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor - Google Patents
Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptorInfo
- Publication number
- AU2002360819A1 AU2002360819A1 AU2002360819A AU2002360819A AU2002360819A1 AU 2002360819 A1 AU2002360819 A1 AU 2002360819A1 AU 2002360819 A AU2002360819 A AU 2002360819A AU 2002360819 A AU2002360819 A AU 2002360819A AU 2002360819 A1 AU2002360819 A1 AU 2002360819A1
- Authority
- AU
- Australia
- Prior art keywords
- cycloheptapyrazole
- cyclohexano
- diseases associated
- derivative compounds
- ht2c receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000006902 5-HT2C Serotonin Receptor Human genes 0.000 title 1
- 108010072553 5-HT2C Serotonin Receptor Proteins 0.000 title 1
- -1 cycloheptapyrazole derivative compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34415001P | 2001-12-28 | 2001-12-28 | |
| US60/344,150 | 2001-12-28 | ||
| PCT/US2002/041637 WO2003057213A2 (en) | 2001-12-28 | 2002-12-28 | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002360819A8 AU2002360819A8 (en) | 2003-07-24 |
| AU2002360819A1 true AU2002360819A1 (en) | 2003-07-24 |
Family
ID=23349268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002360819A Abandoned AU2002360819A1 (en) | 2001-12-28 | 2002-12-28 | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002360819A1 (en) |
| WO (1) | WO2003057213A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004000826A1 (en) | 2003-04-25 | 2005-03-04 | Pfizer | USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129 |
| EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
| US8685924B2 (en) | 2004-08-25 | 2014-04-01 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| US7622492B2 (en) * | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| CA2632284A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 3-amino-2-arylpropyl azaindoles and uses thereof |
| KR20080072753A (en) | 2005-11-30 | 2008-08-06 | 에프. 호프만-라 로슈 아게 | 3-amino-1-arylpropyl indole and aza-substituted indole |
| JP5528699B2 (en) | 2006-05-16 | 2014-06-25 | 武田薬品工業株式会社 | Fused heterocyclic compounds and uses thereof |
| US7897595B2 (en) | 2006-05-26 | 2011-03-01 | Forest Laboratories Holdings Limited | Pyridoazepine derivatives |
| JP2010509201A (en) * | 2006-11-03 | 2010-03-25 | グレンマーク・ファーマシューティカルズ・エスエー | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and methods for their preparation |
| JP5520051B2 (en) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | Condensed pyridine derivatives and uses thereof |
| US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
| EP2556074B1 (en) * | 2010-04-08 | 2015-01-21 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - S.p.A. | Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| JPWO2019131902A1 (en) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | Remedies for stress urinary incontinence and fecal incontinence |
| WO2024140851A1 (en) * | 2022-12-28 | 2024-07-04 | 上海维申医药有限公司 | Toll-like receptor inhibitor, and preparation therefor and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3560986B2 (en) * | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | 5-HT2C receptor agonist and aminoalkylindazole derivative |
| AU727654B2 (en) * | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| GB9819032D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds IV |
| WO2001070702A1 (en) * | 2000-03-17 | 2001-09-27 | Alcon, Inc. | 6-hydroxy-indazole derivatives for treating glaucoma |
| WO2001083487A1 (en) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Froindazole derivative |
| EP1392292B1 (en) * | 2001-06-01 | 2006-03-01 | Alcon, Inc. | Pyranoindazoles and their use for the treatment of glaucoma |
-
2002
- 2002-12-28 WO PCT/US2002/041637 patent/WO2003057213A2/en not_active Ceased
- 2002-12-28 AU AU2002360819A patent/AU2002360819A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002360819A8 (en) | 2003-07-24 |
| WO2003057213A3 (en) | 2004-02-19 |
| WO2003057213A2 (en) | 2003-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002364035A1 (en) | 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
| AU2002360818A1 (en) | 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
| EP1558615B8 (en) | Purine compounds and use thereof as cannabinoid receptor ligands | |
| IL160707A0 (en) | 1, 8-naphthyridine derivatives as antidiabetics | |
| AU2002359163A1 (en) | New use | |
| PL362982A1 (en) | Benzothiophene derivative compounds, process for the preparation and use thereof | |
| AU2001294228A1 (en) | Benzimidazole compounds, process for producing the same and use thereof | |
| AU2002360819A1 (en) | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
| AU2003299648A1 (en) | Substituted 4-phenyl-(1,3)-dioxanes | |
| AU2003271185A1 (en) | Imidazopyridine derivative, process for producing the same, and use | |
| AUPS015902A0 (en) | Hanger bar | |
| AU2001259051A1 (en) | Piperidyindoles as serotonin receptor ligands | |
| HUP0201035A2 (en) | Substituted bezimidazole, the production thereof and the use thereof as means against parasitic protozoa | |
| AU2003300262A1 (en) | Phthalimidylazo dyes, processes for the preparation thereof and the use thereof | |
| AU2002331972A1 (en) | 3,4-methylenedioxy-substituted chalcones as therapeutic agents | |
| AU2001223882A1 (en) | Receptor | |
| FIU20000296U0 (en) | Mechanism for adjusting the chair | |
| AU2002952559A0 (en) | New use | |
| IL157793A0 (en) | Caloporoside derivatives, methods for the production thereof and their use | |
| AU2003231555A1 (en) | Adjuster with caster | |
| AU2001287884A1 (en) | Halogen compounds for use in medicine | |
| AU2003281525A1 (en) | Serotonin receptor | |
| AU2002327093A1 (en) | 1,2-dihydro-2-oxo-1,8-naphthyridine derivative | |
| GB0212233D0 (en) | The chair pinnie | |
| GB0119196D0 (en) | Sheet or the like, for topical therapeutic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |